Delta Asset Management’s Fortress Biotech FBIO Stock Holding History
Bought
Maintained
Sold
Other funds holding FBIO
CH
RA
AC
ACM
NCM
SAM
PAM
Delta Asset Management's FBIO Position: Q4 2023 in Review
Delta Asset Management sold out of Fortress Biotech (FBIO) in Q4 2023, closing a stake of 400 shares — an estimated $1.74K sold.
Delta Asset Management first reported a position in FBIO in Q2 2013 and held it in 25 quarters. The position peaked at $43K in Q2 2013. 42 funds tracked by Wall St. Rank hold FBIO as of Q4 2023.
- Delta Asset Management reported no remaining Fortress Biotech position as of Q4 2023 after selling out during the quarter.
- Delta Asset Management sold 400 Fortress Biotech shares in Q4 2023, an estimated $1.74K.
- Delta Asset Management first reported a position in Fortress Biotech in Q2 2013 and held it in 25 quarters.
- Delta Asset Management's Fortress Biotech position peaked at $43K in Q2 2013.
- 42 funds tracked by Wall St. Rank held Fortress Biotech as of Q4 2023.
Based on Delta Asset Management's 13F filing for Q4 2023, filed 9 Feb 2024.